P-REX2a driving tumorigenesis by PTEN inhibition

Related Experiment Video

Updated: Jun 19, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Nick R Leslie1

  • 1Division of Molecular Physiology, College of Life Sciences, University of Dundee, The James Black Centre, Dow Street, Dundee, DD1 5EH, UK. n.r.leslie@dundee.ac.uk

Science Signaling
|October 29, 2009
PubMed

Insights

The protein P-REX2a directly regulates PTEN, a key tumor suppressor. Aberrant P-REX2a control of PTEN may drive cancer by promoting cell proliferation.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell signaling

Background:

  • PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a crucial tumor suppressor that counteracts phosphoinositide 3-kinase (PI3K) signaling.
  • PTEN is frequently mutated in human cancers, highlighting its complex regulation and clinical significance.
  • P-REX2a (phosphatidylinositol 3,4,5-trisphosphate Rac exchanger 2a) is known to regulate the small GTPase Rac.

Purpose of the Study:

  • To investigate P-REX2a as a direct regulator of PTEN activity.
  • To explore the role of P-REX2a in PTEN-mediated signaling and its potential as an oncoprotein.

Main Methods:

  • The study identified P-REX2a as a direct regulator of PTEN.
  • Investigated the impact of P-REX2a on PTEN activity and downstream signaling pathways.

Main Results:

  • P-REX2a was identified as a direct regulator of PTEN.
  • P-REX2a stimulates cell proliferation by inhibiting PTEN.
  • This inhibition leads to enhanced downstream PI3K-dependent signaling.

Conclusions:

  • Aberrant regulation of PTEN by P-REX2a may be a significant mechanism in tumorigenesis.
  • P-REX2a acts as a potential oncoprotein by promoting cancer cell proliferation.
  • These findings underscore the pathological relevance of PTEN regulators in cancer development.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...